[1] Huang D, Swanson E A, Lin CP, et al. Optical coherence tomography [J]. Science, 1991, 254(5035):1178-1181.
[2] Brezinski M E, Tearney G J, Bouma B E, et al. Imaging of coronary artery microstructure (in vitro) with optical coherence tomography[J]. Am J Cardiol, 1996, 77(1): 92-93.
[3] Kataiwa H, Tanaka A, Kitabata H, et al. Safety and usefulness of non-occlusion image acquisition technique for optical coherence tomography [J]. Circ J, 2008, 72(9):1536-1537.
[4] Takarada S, Imanishi T, Liu Y, et al. Advantage of next-generation frequency-domain optical coherence tomography compared with conventional time-domain system in the assessment of coronary lesion [J]. Catheter Cardiovasc Interv, 2010, 75(2): 202-206.
[5] Jang I K, Bouma B E, Kang D H, et al. Visualization of coronary atherosclerotic plaques in patients using optical coherence tomography: comparison with intravascular ultrasound[J]. J Am Coll Cardiol, 2002, 39(4): 604-609.
[6] Yabushita H, Bouma B E, Houser S L, et al. Characterization of human atherosclerosis by optical coherence tomography [J].Circulation, 2002,106(13):1640-1645.
[7] Ueda T, Uemura S, Watanabe M, et al. Colocalization of thin-cap fibroatheroma and spotty calcification is a powerful predictor of procedure-related myocardial injury after elective coronary stent implantation [J]. Coron Artery Dis, 2014. [Epub ahead of print]
[8] Kume T, Akasaka T, Kawamoto T, et al. Measurement of the thickness of the fibrous cap by optical coherence tomography [J]. Am Heart J, 2006,152(4):755-755.
[9] Virmani R, Kolodgie F D, Burke A P, et al. Lessons from sudden coronary death a comprehensive morphological classification scheme for atherosclerotic lesions[J]. Arterioscler Thromb Vasc Biol, 2000,20(5):1262-1275.
[10] Jang I K, Tearney G J, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography [J].Circulation, 2005,111(12):1551-1555.
[11] Kubo T, Imanishi T, Takarada S, et al. Assessment of culprit lesion morphology in acute myocardial infarction ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy [J]. J Am Coll Cardiol, 2007, 50(10): 933-939.
[12] Roleder T, Kovacic J C, Ali Z, et al. Combined NIRS and IVUS imaging detects vulnerable plaque using a single catheter system: a head-to-head comparison with OCT [J]. EuroIntervention, 2014. [Epub ahead of print]
[13] Kume T, Akasaka T, Kawamoto T, et al. Assessment of coronary arterial thrombus by optical coherence tomography [J]. Am J Cardiol, 2006, 97(12): 1713-1717.
[14] MacNeill B D, Jang I K, Bouma B E, et al. Focal and multi-focal plaque macrophage distributions in patients with acute and stable presentations of coronary artery disease[J]. J Am Coll Cardiol, 2004, 44(5): 972-979.
[15] Manfrini O, Mont E, Leone O, et al. Sources of error and interpretation of plaque morphology by optical coherence tomography [J]. Am J Cardiol, 2006, 98(2): 156-159.
[16] Gonzalo N, Serruys P W, Okamura T, et al. Optical coherence tomography assessment of the acute effects of stent implantation on the vessel wall: a systematic quantitative approach [J]. Heart, 2009, 95(23): 1913-1919.
[17] Terashima M, Rathore S, Suzuki Y, et al. Accuracy and reproducibility of stent-strut thickness determined by optical coherence tomography[J].J Invasive Cardiol, 2009, 21(11): 602-605.
[18] Matsumoto D, Shite J, Shinke T, et al. Neointimal coverage of sirolimus-eluting stents at 6-month follow-up: evaluated by optical coherence tomography[J]. Eur Heart J, 2007, 28(8): 961-967.
[19] Inoue T, Shinke T, Otake H, et al. Impact of strut-vessel distance and underlying plaque type on the resolution of acute strut malapposition: serial optimal coherence tomography analysis after everolimus-eluting stent implantation[J]. Int J cardiovasc imaging, 2014, 30(5): 857-865.
[20] Katoh H, Shite J, Shinke T, et al. Delayed neointimalization on sirolimus-eluting stents: 6-month and 12-month follow up by optical coherence tomography [J]. Circ J, 2009, 73(6): 1033-1037.
[21] Kim J S, Jang I K, Fan C, et al. Evaluation in 3 months duration of neointimal coverage after zotarolimus-eluting stent implantation by optical coherence tomography: the ENDEAVOR OCT trial[J]. JACC Cardiovasc Interv, 2009, 2(12): 1240-1247.
[22] Tanaka N, Terashima M, Rathore S, et al. Different patterns of vascular response between patients with or without diabetes mellitus after drug-eluting stent implantation optical coherence tomographic analysis[J]. JACC Cardiovasc Interv, 2010, 3(10): 1074-1079.
[23] Guagliumi G, Sirbu V. Optical coherence tomography: high resolution intravascular imaging to evaluate vascular healing after coronary stenting [J]. Catheter Cardiovasc Interv, 2008, 72(2): 237-247.
[24] Guagliumi G, Costa M A, Sirbu V, et al. Strut coverage and late malapposition with paclitaxel-eluting stents compared with bare metal stents in acute myocardial infarction optical coherence tomography substudy of the harmonizing outcomes with revascularization and stents in acute myocardial infarction (HORIZONS-AMI) trial[J]. Circulation, 2011, 123(3): 274-281.
[25] Gutiérrez-Chico J L, Regar E, Nüesch E, et al. Delayed coverage in malapposed and side-branch struts with respect to well-apposed struts in drug-eluting stents in vivo assessment with optical coherence tomography[J]. Circulation, 2011, 124(5): 612-623.
[26] Kume T, Akasaka T, Kawamoto T, et al. Visualization of neointima formation by optical coherence tomography [J]. Int Heart J, 2005, 46(6): 1133-1136.
[27] Habara M, Terashima M, Nasu K, et al. Difference of tissue characteristics between early and very late restenosis lesions after bare-metal stent implantation: an optical coherence tomography study [J]. Circ Cardiovasc Interv, 2011, 4(3): 232-238.
[28] Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolucent regions in optical coherence tomography images from two patients with sirolimus-eluting stent restenosis [J]. Catheter Cardiovasc Interv, 2010, 75(6): 961-963.